Journal ArticleBMC Glob Public Health · October 17, 2025
BACKGROUND: Cervical cancer screening using human papillomavirus (HPV) DNA testing is an essential component of prevention efforts. Countries with limited health care infrastructure need innovative strategies to make HPV-based screening feasible. Our team ...
Full textLink to itemCite
Journal ArticleBMJ Glob Health · May 6, 2025
INTRODUCTION: Human papillomavirus (HPV) is the leading source of cervical cancer in Kenya. HPV, like other sexually transmitted infections, is stigmatised, which hinders efforts to address the disease. Education and empowerment are crucial in combating HP ...
Full textLink to itemCite
Journal ArticleJ Low Genit Tract Dis · April 1, 2025
OBJECTIVE: The purpose of this review was to examine new evidence since the authors' 2019 guidelines for cervical cancer (CC) screening in non-HIV immunocompromised persons and to provide updated recommendations based on literature review and expert opinio ...
Full textLink to itemCite
Journal ArticleBiomed Signal Process Control · February 2025
UNLABELLED: The proportion of women dying from cervical cancer in middle- and low-income countries is over 60%, twice that of their high-income counterparts. A primary screening strategy to eliminate this burden is cervix visualization and application of 3 ...
Full textLink to itemCite
ConferenceProgress in Biomedical Optics and Imaging Proceedings of SPIE · January 1, 2025
Globally, inequitable resources and access cause cervical cancer remain the fourth leading cause of death in women. Risk stratification with human papilloma virus (HPV) screening is fundamental in identifying vulnerable populations. Visual inspection with ...
Full textCite
Journal ArticleRes Sq · December 18, 2024
BACKGROUND: Cervical cancer is the fourth most common cancer among women with significant global disparities in disease burden. In lower-resource settings, where routine screening is uncommon, delays in diagnosis and treatment contribute to morbidity and m ...
Full textLink to itemCite
Journal ArticleAIDS · December 1, 2024
OBJECTIVE: To compare the model-predicted benefits, harms, and cost-effectiveness of cytology, cotesting, and primary HPV screening in US women with HIV (WWH). DESIGN: We adapted a previously published Markov decision model to simulate a cohort of US WWH. ...
Full textLink to itemCite
Journal ArticleBMC Womens Health · September 2, 2024
BACKGROUND: More efficient methods to detect and treat precancerous lesions of the cervix at a single visit, such as low-cost confocal microscopy, could improve early diagnosis and hence outcomes. We piloted a prototype smartphone-compatible confocal micro ...
Full textLink to itemCite
Journal ArticleBMC Womens Health · January 13, 2024
BACKGROUND: Mobile health (mHealth) has become an increasingly popular strategy to improve healthcare delivery and health outcomes. Communicating results and health education via text may facilitate program planning and promote better engagement in care fo ...
Full textLink to itemCite
Journal ArticleObstet Gynecol · December 1, 2023
OBJECTIVE: To compare contraceptive provision to women with and without intellectual and developmental disabilities enrolled in North Carolina Medicaid. METHODS: Our retrospective cohort study used 2019 North Carolina Medicaid claims to identify women aged ...
Full textLink to itemCite
Journal ArticleObstet Gynecol · October 26, 2023
OBJECTIVE: To compare contraceptive provision to women with and without intellectual and developmental disabilities enrolled in North Carolina Medicaid. METHODS: Our retrospective cohort study used 2019 North Carolina Medicaid claims to identify women aged ...
Full textLink to itemCite
Journal ArticleRes Sq · June 9, 2023
BACKGROUND: Mobile health (mHealth) has become an increasingly popular strategy to improve healthcare delivery and health outcomes. Communicating results and health education via text may facilitate program planning and promote better engagement in care fo ...
Full textLink to itemCite
Journal ArticleOncologist · January 18, 2023
BACKGROUND: Cervical cancer screening through self-collected high-risk human papillomavirus (HPV) testing has increased screening uptake, particularly in low-resource settings. Improvement ultimately depends, however, on women with positive results accessi ...
Full textLink to itemCite
Journal ArticlePLOS Glob Public Health · 2023
High rates of maternal and neonatal morbidity and mortality in Kenya may be influenced by provider training and knowledge in emergency obstetric and neonatal care in addition to availability of supplies necessary for this care. While post-abortion care is ...
Full textLink to itemCite
Journal ArticlePLOS Glob Public Health · 2023
Despite prevalent preventative methods of human papillomavirus (HPV), cervical cancer remains the foremost cause of cancer-related death among women of reproductive age in Western Kenya. HPV self-sampling is a preventative measure that can improve accessib ...
Full textLink to itemCite
Journal ArticleOxford Open Digital Health · January 1, 2023
AbstractThe use of big data sources, like Twitter, and big data analytical techniques, like machine learning, have increased in popularity in almost every area of scientific inquiry. However, recent reviews ...
Full textCite
Dataset · September 14, 2022
We conducted a cross-sectional survey of providers at health facilities in western Kenya providing inpatient maternity services. Providers estimated facility capacity through perceived availability of both general and specialized supplies. Providers report ...
Full textCite
Journal ArticleInt Urogynecol J · September 2022
INTRODUCTION AND HYPOTHESIS: Visual tools are a valuable tool for ascertaining patient symptoms, especially in populations with low literacy rates. The objective was to develop and validate a pictorial scale for assessing symptomatic pelvic organ prolapse ...
Full textLink to itemCite
Journal ArticleJ Cancer Educ · August 2022
About nine out of 10 cervical cancer deaths occur in low-resource countries, with a particularly high burden in sub-Saharan Africa. The objectives of this study were to assess barriers and facilitators to cervical cancer screening in western Kenya from the ...
Full textLink to itemCite
Journal ArticleJMIR Form Res · June 23, 2022
BACKGROUND: There is growing evidence supporting the use of mobile health (mHealth) interventions in low- and middle-income countries to address resource limitations in the delivery of health information and services to vulnerable populations. In parallel, ...
Full textLink to itemCite
Journal ArticleJMIR Public Health Surveill · June 7, 2022
BACKGROUND: Mobile phone ownership among women of reproductive age in western Kenya is not well described, and our understanding of its link with care-seeking behaviors is nascent. Understanding access to and use of mobile phones among this population as w ...
Full textLink to itemCite
Journal ArticleBMC Womens Health · April 18, 2022
INTRODUCTION: Despite the increased risk of cervical cancer among HIV-positive women, many HIV-care programs do not offer integrated cervical cancer screening. Incorporating self-collected Human Papillomavirus (HPV) testing into HIV programs is a potential ...
Full textLink to itemCite
Journal ArticleJMIR Form Res · February 24, 2022
BACKGROUND: To achieve the World Health Organization targets for cervical cancer elimination, low- and middle-income countries will need to develop innovative strategies to provide human papillomavirus (HPV)-based screening at a population level. Although ...
Full textLink to itemCite
Journal ArticleBMC Womens Health · February 11, 2022
BACKGROUND: Despite a high prevalence of human papillomavirus (HPV) and cervical cancer in low and middle-income countries, stigma remains an issue. Addressing HPV and cervical cancer stigma could significantly improve health outcomes for these conditions. ...
Full textLink to itemCite
Journal ArticleBMC Womens Health · August 18, 2021
BACKGROUND: Cervical cancer is a leading cause of cancer deaths among women of reproductive age in Peru. Screening and early identification of pre-cancerous lesions are a cornerstone of the cervical cancer prevention strategy. Yet, there is limited literat ...
Full textLink to itemCite
Journal ArticleJ Med Internet Res · May 27, 2021
BACKGROUND: Nearly 90% of deaths due to cervical cancer occur in low- and middle-income countries (LMICs). In recent years, many digital health strategies have been implemented in LMICs to ameliorate patient-, provider-, and health system-level challenges ...
Full textLink to itemCite
Journal ArticleClin Infect Dis · May 4, 2021
BACKGROUND: Primary human papillomavirus (HPV) screening (PHS) utilizes oncogenic human papillomavirus (oncHPV) testing as the initial cervical cancer screening method and typically, if positive, additional reflex-triage (eg, HPV16/18-genotyping, Pap testi ...
Full textLink to itemCite
Journal ArticlePrev Med · March 2021
The World Health Organization (WHO) is leading a call to action to eliminate cervical cancer by the end of the century through global implementation of two effective evidence-based preventive interventions: HPV vaccination and cervical screening and manage ...
Full textLink to itemCite
Journal ArticleInt J Gynaecol Obstet · January 2021
OBJECTIVE: To evaluate access to treatment after community-based HPV testing as testing within screen-and-treat programs has the potential to lower mortality from cervical cancer in low-resource settings. METHODS: A prospective cohort study was conducted i ...
Full textLink to itemCite
Journal ArticleBMJ Open · December 12, 2020
OBJECTIVES: This study aimed to report the proportion of women with a new diagnosis of cervical cancer recommended for curative hysterectomy as well as associated factors. We also report recommended treatments by stage and patterns of treatment initiation. ...
Full textLink to itemCite
Journal ArticlePrev Med Rep · December 2020
Cervical cancer mortality is high among Peruvian women of reproductive age. Understanding barriers and facilitators of cervical cancer screening and treatment could facilitate development of contextually-relevant interventions to reduce cervical cancer inc ...
Full textLink to itemCite
Journal ArticleCancer Med · November 2020
The World Health Organization (WHO) refers to cervical cancer as a public health problem, and sub-Saharan Africa bears the world's highest incidence. In the realm of screening, simplified WHO recommendations for low-resource countries now present an opport ...
Full textLink to itemCite
Journal ArticleBMJ Open · October 27, 2020
OBJECTIVES: To estimate the cost of human papillomavirus (HPV)-based screening through community health campaigns (CHCs) and home-based testing. SETTING: CHCs and home-based testing in six communities in rural Western Kenya. PARTICIPANTS: CHCs and home-bas ...
Full textLink to itemCite
Journal ArticleScientific reports · October 2020
Fear of the speculum and feelings of vulnerability during the gynecologic exams are two of the biggest barriers to cervical cancer screening for women. To address these barriers, we have developed a novel, low-cost tool called the Callascope to reimagine t ...
Full textCite
Journal Article · August 17, 2020
BACKGROUNDNearly 90% of deaths due to cervical cancer occur in low- and middle-income countries (LMICs). In recent years, many digital health strategies have been implemented in LMICs to ...
Full textCite
Journal ArticleJCO Glob Oncol · July 2020
PURPOSE: The WHO now recommends thermal ablation as an alternative to cryotherapy within "screen-and-treat" cervical cancer programs in low- and middle-income countries (LMICs). We conducted a safety and acceptability clinical trial of thermal ablation in ...
Full textLink to itemCite
Journal ArticleVaccine · June 15, 2020
It is unknown whether the HPV vaccine is effective in immunocompromised women during catch-up ages. We performed a case-control study of 4,357 women with incident CIN2+ (cases) and 5:1 age-matched, incidence-density selected controls (N = 21,773) enrolled ...
Full textLink to itemCite
Journal ArticleJCO Glob Oncol · April 2020
PURPOSE: Cervical cancer screening is not well implemented in many low- and middle-income countries (LMICs). Mobile health (mHealth) refers to utilization of mobile technologies in health promotion and disease management. We aimed to qualitatively synthesi ...
Full textLink to itemCite
Journal ArticleCult Med Psychiatry · March 2020
In the United States, the historical condemnation and punitive legal consequences of substance use during pregnancy-ranging from incarceration to termination of parental custody of a newborn-render pregnant women in state of biosocial precarity. Yet pregna ...
Full textLink to itemCite
Journal ArticleInt J Gynaecol Obstet · March 2020
OBJECTIVE: To characterize the efficiency of screening through high-volume community health campaigns (CHCs) by comparing the costs and population reach and identify factors associated with gains in efficiency. Access to effective cervical cancer screening ...
Full textLink to itemCite
Journal ArticleJ Cancer Educ · February 2020
Detection and treatment of human papillomavirus (HPV) and cervical precancer through screening programs is an effective way to reduce cervical cancer deaths. However, high cervical cancer mortality persists in low- and middle-income countries. As screening ...
Full textLink to itemCite
Journal ArticleBMJ Open · January 6, 2020
OBJECTIVE: Previous studies identified several factors associated with cervical cancer screening. However, many of them used samples from the general population and limited studies focused on women with high-risk health behaviours. We aimed to disentangle ...
Full textLink to itemCite
Journal ArticlePLoS One · 2020
OBJECTIVE: To identify health systems-level barriers to treatment for women who screened positive for high-risk human papillomavirus (hrHPV) in a cervical cancer prevention program in Kenya. METHODS: In a trial of implementation strategies for hrHPV-based ...
Full textLink to itemCite
Journal ArticleMDM Policy Pract · 2020
Purpose. In 2018, the US Preventive Services Task Force (USPSTF) endorsed three strategies for cervical cancer screening in women ages 30 to 65: cytology every 3 years, testing for high-risk types of human papillomavirus (hrHPV) every 5 years, and cytology ...
Full textOpen AccessLink to itemCite
Journal ArticleGlob Health Sci Pract · December 23, 2019
We applied a novel approach to visualizing contraceptive histories from the Demographic and Health Surveys (DHS) contraceptive calendar to elucidate patterns of contraceptive switching and discontinuation (e.g., "churn" in contraceptive use across 2 points ...
Full textLink to itemCite
Journal ArticleBMC Womens Health · August 8, 2019
BACKGROUND: To be effective, population-based cervical cancer prevention programs must be tailored to meet the needs of the target population. One important factor in cervical cancer screening may include male involvement. To iteratively improve a screenin ...
Full textLink to itemCite
Journal ArticleBMJ Open · July 24, 2019
BACKGROUND: We sought to understand the beliefs, social norms and logistical factors that affect human papillomavirus (HPV)-positive women's uptake of cryotherapy treatment as part of a two-part cervical cancer screening strategy in rural Kenya. METHODS: I ...
Full textLink to itemCite
Journal ArticleJAMA Intern Med · July 1, 2019
IMPORTANCE: Many cervical cancer screening strategies are now recommended in the United States, but the benefits, harms, and costs of each option are unclear. OBJECTIVE: To estimate the cost-effectiveness of 12 cervical cancer screening strategies. DESIGN, ...
Full textLink to itemCite
Journal ArticleBMC Womens Health · June 13, 2019
BACKGROUND: Despite cervical cancer being preventable with effective screening programs, it is the most common cancer and the leading cause of cancer-related death among women in many countries in Africa. Screening involving pelvic examination may not be f ...
Full textLink to itemCite
Journal ArticleJ Glob Oncol · June 2019
PURPOSE: Human papillomavirus (HPV) testing is being more widely used in simplified cervical cancer screening protocols in low-resource settings. One challenge to successful implementation is the multiple visits necessary to provide results and follow-up. ...
Full textLink to itemCite
Journal ArticleJ Low Genit Tract Dis · April 2019
EXECUTIVE SUMMARY: The risk of cervical cancer (CC) among women immunosuppressed for a variety of reasons is well documented in the literature. Although there is improved organ function, quality of life and life expectancy gained through use of immunosuppr ...
Full textLink to itemCite
Journal ArticleInfect Agent Cancer · 2019
BACKGROUND: New strategies are needed to combat the high incidence of cervical cancer in resource-limited settings such as sub-Saharan Africa. Screening for high-risk human papillomavirus (hrHPV) DNA is sensitive for pre-cancer, but its lack of specificity ...
Full textLink to itemCite
Journal ArticlePLoS One · 2019
OBJECTIVE: To identify patient factors associated with whether women who screened positive for high-risk human papillomavirus (hrHPV) successfully accessed treatment in a cervical cancer prevention program in Kenya. METHODS: A prospective cohort study was ...
Full textLink to itemCite
Journal Article · 2019
Background Invasive cervical cancer is preventable, yet affects 500,000 women worldwide each year, and over half these women die. Barriers to cervical cancer screening include lack of awareness of cervical cancer and the cervix, fear of the specul ...
Full textCite
Journal ArticleLancet Child Adolesc Health · October 2018
BACKGROUND: The population effectiveness of human papillomavirus (HPV) catch-up vaccination, defined in the USA as first vaccination at ages 13-26 years, has not been studied extensively. We aimed to assess the risk of cervical intraepithelial neoplasia (C ...
Full textLink to itemCite
Journal ArticleBMC Womens Health · July 3, 2018
BACKGROUND: The incidence of cervical cancer in Kenya is among the highest in the world. Few Kenyan women are able to access screening, thus fueling the high cervical cancer burden. Self-collected human papilloma Virus (HPV) tests, administered during comm ...
Full textLink to itemCite
Journal ArticleAIDS · July 1, 2018
OBJECTIVE: The remarkable progress made in confronting the global HIV epidemic offers a unique opportunity to address the increasing threat of noncommunicable diseases (NCDs). However, questions remain about how to enhance the HIV platforms to deliver inte ...
Full textLink to itemCite
Journal ArticleBMC Health Serv Res · May 25, 2018
BACKGROUND: Cervical cancer is the most frequent neoplasm among Kenyan women, with 4800 diagnoses and 2400 deaths per year. One reason is an extremely low rate of screening through pap smears, at 13.8% in 2014. Knowing the costs of screening will help plan ...
Full textLink to itemCite
Journal ArticleGynecol Oncol Rep · May 2018
There is significant disparity in the prevalence of cervical cancer globally, with low- and middle-income countries (LMICs) shouldering a disproportionate share of disease incidence and an even greater proportion of morbidity and mortality. Available resou ...
Full textLink to itemCite
Journal ArticleInt J Gynaecol Obstet · April 2018
OBJECTIVE: To determine the effectiveness of community health campaigns (CHCs) as a strategy for human papillomavirus (HPV)-based cervical cancer screening in rural western Kenya. METHODS: Between January and November 2016, a cluster-randomized trial was c ...
Full textLink to itemCite
Journal ArticleObstet Gynecol · January 2018
OBJECTIVE: To estimate the risk of cervical intraepithelial neoplasia grade 2, 2-3, 3, adenocarcinoma in situ, or cancer (CIN 2 or worse) among women with human immunodeficiency virus (HIV)- and non-HIV-associated immunosuppression. METHODS: We performed a ...
Full textLink to itemCite
Journal ArticleGlob Health Action · 2018
BACKGROUND: Improving patient flow and reducing over-crowding can improve quality, promptness of care, and patient satisfaction. Given low utilization of preventive care in low-resource countries, improved patient flows are especially important in these se ...
Full textOpen AccessLink to itemCite
Journal ArticleBMC Cancer · December 6, 2017
BACKGROUND: Despite guidelines for cervical cancer prevention in low-resource countries, a very small proportion of women in these settings undergo screening, and even fewer women are successfully treated. Using pilot data from western Kenya and World Heal ...
Full textLink to itemCite
Journal ArticleJ Biosoc Sci · November 2017
This paper reviews the literature examining the relationship between women's empowerment and contraceptive use, unmet need for contraception and related family planning topics in developing countries. Searches were conducted using PubMed, Popline and Web o ...
Full textLink to itemCite
Journal ArticleMed Clin North Am · July 2017
Cervical cancer screening in the United States has accompanied profound decreases in cancer incidence and mortality over the last half century. Two screening strategies are currently endorsed by US-based guideline groups: (1) triennial cytology for women a ...
Full textLink to itemCite
Journal ArticleBMJ Open · September 13, 2016
OBJECTIVE: A biomarker with increased specificity for cervical dysplasia compared with human papillomavirus (HPV) testing would be an attractive option for cervical cancer screening among HIV-infected women in resource-limited settings. p16(INK4a) has been ...
Full textLink to itemCite
Journal ArticleJ Cancer Educ · June 2016
Cervical cancer is a leading cause of cancer-related death amongst women in sub-Saharan Africa, largely due to the lack of early screening and treatment. In addition to poor access to screening services, inadequate uptake of available services is a barrier ...
Full textLink to itemCite
Journal ArticleJ Cancer Educ · September 2015
Cervical cancer is a highly preventable disease that disproportionately affects women in developing countries and women with HIV. As integrated HIV and cervical cancer screening programs in Sub-Saharan Africa mature, we have an opportunity to measure the i ...
Full textLink to itemCite
Journal ArticleObstet Gynecol · August 2015
Prenatal care providers are frequently asked to provide employment notes for their patients requesting medical leave or changes to work duties. Writing employment notes correctly can help patients negotiate for and obtain medically indicated workplace acco ...
Full textLink to itemCite
Journal ArticleJ Community Health · August 2015
Although cervical cancer is highly preventable through screening, it remains the number one cause of cancer-related death in Kenyan women due to lack of funding and infrastructure for prevention programs. In 2012, Family AIDS Care and Education Services in ...
Full textLink to itemCite
Journal ArticlePatient Educ Couns · July 2015
OBJECTIVE: Cervical cancer screening uptake may be influenced by inadequate knowledge in resource-limited settings. This randomized trial evaluated a health talk's impact on cervical cancer knowledge, attitudes, and screening rates in rural Kenya. METHODS: ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · June 1, 2015
INTRODUCTION: HIV-infected women may have higher rates of recurrent cervical precancer after treatment. Knowledge about rates and predictors of recurrence could impact guidelines and program planning, especially in low-resource settings. METHODS: In this p ...
Full textLink to itemCite
Journal ArticleInt J Gynaecol Obstet · March 2015
OBJECTIVE: To evaluate cervical cancer knowledge, risk perception, and screening intention among women attending outpatient clinics in rural Kenya. METHODS: A cross-sectional oral survey was conducted among non-pregnant women aged 23-64 years who attended ...
Full textLink to itemCite
Journal ArticleInt J Cancer · January 15, 2015
Visual inspection with acetic acid (VIA) is becoming a more widely recommended and implemented screening tool for cervical cancer prevention programs in low-resource settings. Many of these settings have a high prevalence of HIV-infected women. We carried ...
Full textLink to itemCite
Journal ArticlePLoS One · 2015
BACKGROUND: HIV increases women's risk for high-risk human papillomavirus (hrHPV) infection and invasive cervical cancer. South Africa has a high HIV prevalence but low cervical cancer screening coverage. Self-collection of cervical specimens and hrHPV tes ...
Full textLink to itemCite
Journal ArticleJ Int AIDS Soc · 2015
INTRODUCTION: HIV and cervical cancer are intersecting epidemics that disproportionately affect one of the most vulnerable populations in the world: women in low- and middle-income countries (LMICs). Historically, the disparity in cervical cancer risk for ...
Full textLink to itemCite
Journal ArticlePLoS One · 2015
Visual inspection with Acetic Acid (VIA) and Visual Inspection with Lugol’s Iodine (VILI) are increasingly recommended in various cervical cancer screening protocols in low-resource settings. Although VIA is more widely used, VILI has been advocated as an ...
Full textOpen AccessLink to itemCite
Journal ArticleBMC Womens Health · November 22, 2014
BACKGROUND: A number of studies have identified male involvement as an important factor affecting reproductive health outcomes, particularly in the areas of family planning, antenatal care, and HIV care. As access to cervical cancer screening programs impr ...
Full textOpen AccessLink to itemCite
Journal ArticleSoc Sci Med · August 2014
Women's empowerment has become a focal point for development efforts worldwide and there is a need for an updated, critical assessment of the existing evidence on women's empowerment and fertility. We conducted a literature review on studies examining the ...
Full textLink to itemCite
Journal ArticleJ Acquir Immune Defic Syndr · June 1, 2014
HIV-infected women are at increased risk for recurrence of cervical dysplasia after treatment. Short-term recurrence rates may reflect treatment efficacy and therefore impact screening protocols and follow-up planning. We conducted a prospective study of 2 ...
Full textLink to itemCite
Journal ArticleBull World Health Organ · March 1, 2014
OBJECTIVE: To determine the optimal strategy for cervical cancer screening in women with human immunodeficiency virus (HIV) infection by comparing two strategies: visual inspection of the cervix with acetic acid (VIA) and VIA followed immediately by visual ...
Full textLink to itemCite
Journal ArticleInt J Cancer · February 1, 2014
HIV and cervical cancer are intersecting epidemics in many low-resource settings, yet there are few accurate estimates of the scope of this public health challenge. To understand disease prevalence and risk factors for cervical intraepithelial neoplasia 2 ...
Full textLink to itemCite
Journal ArticlePLoS One · 2014
OBJECTIVE: To demonstrate the application of causal inference methods to observational data in the obstetrics and gynecology field, particularly causal modeling and semi-parametric estimation. BACKGROUND: Human immunodeficiency virus (HIV)-positive women a ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Gynaecol Obstet · December 2013
OBJECTIVE: To determine the prevalence of invasive cervical cancer (ICC) and assess access to, and outcomes of, treatment for ICC among HIV-infected women in Kisumu, Kenya. METHODS: We performed a retrospective chart review to identify women diagnosed with ...
Full textLink to itemCite
Journal ArticleBJOG · September 2013
OBJECTIVE: We sought to examine the impact of the loop electrosurgical excision procedure (LEEP) on the rate and magnitude of HIV-1 genital shedding among women undergoing treatment for cervical intraepithelial neoplasia 2/3 (CIN2/3). DESIGN: Prospective c ...
Full textLink to itemCite
Journal ArticlePLoS Med · August 2013
Ruby Singhrao and colleagues propose four arguments for why cervical cancer screening and treatment should be prioritized. Please see later in the article for the Editors' Summary ...
Full textLink to itemCite
Journal ArticleAIDS Res Hum Retroviruses · July 2013
HIV-1 genital shedding is associated with increased HIV-1 transmission risk. Inflammation and ulceration are associated with increased shedding, while highly active antiretroviral therapy (HAART) has been shown to have a protective effect. We sought to exa ...
Full textLink to itemCite
Journal ArticleJ Low Genit Tract Dis · July 2013
OBJECTIVE: Given the high prevalence of cervical intraepithelial neoplasia (CIN) grade 2/3 among HIV-infected women, we sought to examine the relationship between CIN 2/3 and HIV-1 genital shedding among women on highly active antiretroviral therapy (HAART ...
Full textLink to itemCite
Journal ArticleAm J Obstet Gynecol · May 2013
Our objective was to assess the sensitivity and specificity of human papillomavirus (HPV) testing for cervical cancer screening in randomized trials. We conducted a systematic literature search of the following databases: MEDLINE, CINAHL, EMBASE, and Cochr ...
Full textLink to itemCite
Journal ArticleSex Transm Dis · February 2013
In resource-limited settings, detection of sexually transmitted infections (STIs) often relies on self-reported symptoms to initiate management. We found self-report demonstrated poor sensitivity for STI detection. Adding clinician-initiated questions abou ...
Full textLink to itemCite
Journal ArticleObstet Gynecol · September 2011
OBJECTIVES: To estimate the safety, tolerability, and acceptability of loop electrosurgical excision procedure (LEEP) for cervical intraepithelial neoplasia (CIN 2 or 3) in human immunodeficiency virus (HIV)-positive women performed by nonphysician health ...
Full textLink to itemCite
Journal ArticleInt J Gynaecol Obstet · August 2011
OBJECTIVE: To evaluate outcomes of cervical cancer screening within HIV care and treatment clinics in Kenya. METHODS: Beginning in October 2007, visual inspection with acetic acid (VIA), colposcopy, and loop electrosurgical excision procedure (LEEP) were a ...
Full textLink to itemCite
Journal ArticleSexually Transmitted Infections · July 2011
BackgroundControl of sexually transmitting infections (STIs) is an important aspect of HIV prevention and care. Syndromic management for vaginal discharge, despite a recognised low sensitivity and specificity, is ...
Full textCite
Journal ArticleAIDS Behav · May 2011
HIV testing has been promoted as a key HIV prevention strategy in low-resource settings, despite studies showing variable impact on risk behavior. We sought to examine rates of HIV testing and the association between testing and sexual risk behaviors in Ki ...
Full textOpen AccessLink to itemCite
Journal ArticleInt J Gynaecol Obstet · October 2010
Outpatient treatment of cervical precancer using LEEP was performed safely and effectively by nonphysician healthcare workers in an HIV primary care clinic in Kisumu, Kenya. ...
Full textLink to itemCite
Journal ArticleFertil Steril · July 2005
OBJECTIVE: To discuss the diagnosis and management of rectus sheath hematomas after transvaginal follicle aspiration. DESIGN: Case report. SETTING: A single healthy patient in an academic IVF center. PATIENT(S): A healthy patient undergoing routine transva ...
Full textLink to itemCite